Upstream Bio (UPB) Non-Current Assets (2023 - 2026)

Upstream Bio's Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 25.48% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $8.2 million (down 22.64% YoY), while the FY2025 annual figure was $2.0 million, down 22.82% from the prior year.
• Non-Current Assets for Q1 2026 stood at $1.8 million, down from $2.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $5.4 million in Q3 2024, with the low at $202000.0 in Q4 2023.
• The 4-year median for Non-Current Assets is $2.2 million (2025), against an average of $2.3 million.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 1166.83% in 2024, then tumbled 59.87% in 2025.
• Upstream Bio's Non-Current Assets stood at $202000.0 in 2023, then jumped by 1166.83% to $2.6 million in 2024, then retreated by 22.82% to $2.0 million in 2025, then fell by 10.13% to $1.8 million in 2026.
• Business Quant data shows UPB's Non-Current Assets at $1.8 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.